Pharma Industry News

Pfizer’s pneumococcal vaccine approved by the FDA for adults aged 18 years or older

Vaccine helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia

Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]